Description
CJC-1295 (no DAC) and GHRP-2 is a research peptide blend developed to examine synergistic stimulation of the growth hormone axis through dual receptor pathways. CJC-1295 (Mod GRF 1–29) activates the GHRH receptor, initiating cAMP/PKA signaling and GH synthesis, while GHRP-2 binds to the ghrelin receptor (GHS-R1a), triggering Gq/11-mediated calcium influx. This blend is utilized in preclinical studies investigating hypothalamic–pituitary coordination, peptide receptor interaction, and pulsatile hormone release mechanisms.
For research use only. Not for human consumption.
References:
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Kojima M et al., Nature, 1999 402(6762):656–660
Reviews
There are no reviews yet.